Hibsago (bepirovirsen) approved in the US for the treatment of chronic hepatitis B (CHB) Approval based on phase III data ...

GSK Presents First Global Data for Ris-Rez in Extensive-Stage Small Cell Lung Cancer 61% overall response rate in phase Ib ...

YEAR ENDED 31 DECEMBER 2025 Solid H1 trading and despite challenging markets, our margins have remained strong. A record ...

UK markets moved into positive territory following a volatile week, with the FTSE 100 rising 0.33% to around 10,530 points at the time of writing. The ...

UK markets pulled back this week, with the FTSE 100 Index falling 2.12% to trade at around 10,495 points at the time of writing. Despite the broader weakness, UK housebuilders rallied after the ...

* Like-for-like (LFL) company-managed shop sales performance against comparable period in 2025 In the third quarter of 2026, Greggs delivered 7.7% sales growth, with LFL sales in company-managed shops ...

Goodwin PLC provides the following update on trading for the four months ended 31 August 2026 (“the Period”), focusing on the businesses that will remain within the Group following completion of the ...

UK markets were slightly weaker this week, with the FTSE 100 Index down 0.2% to 10,720 points at the time of writing. The outlook for interest rates remains uncertain, with differing views over how ...

Will Lee, Chief Executive Officer, commented: “We made excellent progress in FY2026, with growth in all three segments. We are well positioned in attractive markets that offer substantial ...

Diageo plc (“Diageo”) today announces that Joanne Wilson will join the company as Chief Financial Officer, joining Diageo’s Board and Executive Committee some time in 2027, replacing Nik Jhangiani.

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of exacerbation history Alberto Papi, Professor and Chair of Respiratory ...